BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 25954090)

  • 21. Protection from right- and left-sided colorectal neoplasms after colonoscopy: population-based study.
    Brenner H; Hoffmeister M; Arndt V; Stegmaier C; Altenhofen L; Haug U
    J Natl Cancer Inst; 2010 Jan; 102(2):89-95. PubMed ID: 20042716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic syndrome and smoking may justify earlier colorectal cancer screening in men.
    Chang LC; Wu MS; Tu CH; Lee YC; Shun CT; Chiu HM
    Gastrointest Endosc; 2014 Jun; 79(6):961-9. PubMed ID: 24472766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diet, gender, and colorectal neoplasia.
    Jacobs ET; Thompson PA; Martínez ME
    J Clin Gastroenterol; 2007 Sep; 41(8):731-46. PubMed ID: 17700421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of colorectal cancer after negative colonoscopy: a population-based study.
    Singh H; Nugent Z; Mahmud SM; Demers AA; Bernstein CN
    Am J Gastroenterol; 2010 Mar; 105(3):663-73; quiz 674. PubMed ID: 19904239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns of colorectal cancer screening uptake among men and women in the United States.
    Meissner HI; Breen N; Klabunde CN; Vernon SW
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):389-94. PubMed ID: 16492934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sex- and site-specific differences in colorectal cancer risk among people with type 2 diabetes.
    Overbeek JA; Kuiper JG; van der Heijden AAWA; Labots M; Haug U; Herings RMC; Nijpels G
    Int J Colorectal Dis; 2019 Feb; 34(2):269-276. PubMed ID: 30421309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical outcomes from the CDC's Colorectal Cancer Screening Demonstration Program.
    Seeff LC; Royalty J; Helsel WE; Kammerer WG; Boehm JE; Dwyer DM; Howe WR; Joseph D; Lane DS; Laughlin M; Leypoldt M; Marroulis SC; Mattingly CA; Nadel MR; Phillips-Angeles E; Rockwell TJ; Ryerson AB; Tangka FK
    Cancer; 2013 Aug; 119 Suppl 15():2820-33. PubMed ID: 23868476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinically relevant, gender-specific differences in colorectal carcinoma (CRC)].
    Höffken N; Leichsenring J; Reinacher-Schick A
    Z Gastroenterol; 2015 Aug; 53(8):782-8. PubMed ID: 26284326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonpolypoid colorectal neoplasms: gender differences in prevalence and malignant potential.
    Rondagh EJ; Masclee AA; van der Valk ME; Winkens B; de Bruïne AP; Kaltenbach T; Soetikno RM; Sanduleanu S
    Scand J Gastroenterol; 2012 Jan; 47(1):80-8. PubMed ID: 22149943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Asia-Pacific Colorectal Screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects.
    Yeoh KG; Ho KY; Chiu HM; Zhu F; Ching JY; Wu DC; Matsuda T; Byeon JS; Lee SK; Goh KL; Sollano J; Rerknimitr R; Leong R; Tsoi K; Lin JT; Sung JJ;
    Gut; 2011 Sep; 60(9):1236-41. PubMed ID: 21402615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of developing colorectal cancer following a negative colonoscopy examination: evidence for a 10-year interval between colonoscopies.
    Singh H; Turner D; Xue L; Targownik LE; Bernstein CN
    JAMA; 2006 May; 295(20):2366-73. PubMed ID: 16720822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Risk Prediction Index for Advanced Colorectal Neoplasia at Screening Colonoscopy.
    Schroy PC; Wong JB; O'Brien MJ; Chen CA; Griffith JL
    Am J Gastroenterol; 2015 Jul; 110(7):1062-71. PubMed ID: 26010311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Participation and detection rates by age and sex for colonoscopy versus fecal immunochemical testing in colorectal cancer screening.
    Salas D; Vanaclocha M; Ibáñez J; Molina-Barceló A; Hernández V; Cubiella J; Zubizarreta R; Andreu M; Hernández C; Pérez-Riquelme F; Cruzado J; Carballo F; Bujanda L; Sarasqueta C; Portillo I; de la Vega-Prieto M; Morillas JD; Valentín V; Lanas A; Quintero E; Castells A
    Cancer Causes Control; 2014 Aug; 25(8):985-97. PubMed ID: 24859111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Men with negative results of guaiac-based fecal occult blood test have higher prevalences of colorectal neoplasms than women with positive results.
    Brenner H; Hoffmeister M; Birkner B; Stock C
    Int J Cancer; 2014 Jun; 134(12):2927-34. PubMed ID: 24374771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors associated with false-positive and false-negative fecal immunochemical test results for colorectal cancer screening.
    Wong MC; Ching JY; Chan VC; Lam TY; Luk AK; Ng SS; Sung JJ
    Gastrointest Endosc; 2015 Mar; 81(3):596-607. PubMed ID: 25293827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sex-specific prevalence of adenomas, advanced adenomas, and colorectal cancer in individuals undergoing screening colonoscopy.
    Ferlitsch M; Reinhart K; Pramhas S; Wiener C; Gal O; Bannert C; Hassler M; Kozbial K; Dunkler D; Trauner M; Weiss W
    JAMA; 2011 Sep; 306(12):1352-8. PubMed ID: 21954479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sustained participation, colonoscopy uptake and adenoma detection rates over two rounds of the Tallaght-Trinity College colorectal cancer screening programme with the faecal immunological test.
    McNamara D; Leen R; Seng-Lee C; Shearer N; Crotty P; Neary P; Walsh P; Boran G; O'Morain C
    Eur J Gastroenterol Hepatol; 2014 Dec; 26(12):1415-21. PubMed ID: 25244415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A review of sex-related differences in colorectal cancer incidence, screening uptake, routes to diagnosis, cancer stage and survival in the UK.
    White A; Ironmonger L; Steele RJC; Ormiston-Smith N; Crawford C; Seims A
    BMC Cancer; 2018 Sep; 18(1):906. PubMed ID: 30236083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are there gender differences in colorectal cancer test use prevalence and correlates?
    McQueen A; Vernon SW; Meissner HI; Klabunde CN; Rakowski W
    Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):782-91. PubMed ID: 16614124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combining risk factors with faecal immunochemical test outcome for selecting CRC screenees for colonoscopy.
    Stegeman I; de Wijkerslooth TR; Stoop EM; van Leerdam ME; Dekker E; van Ballegooijen M; Kuipers EJ; Fockens P; Kraaijenhagen RA; Bossuyt PM
    Gut; 2014 Mar; 63(3):466-71. PubMed ID: 23964098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.